Drawing for EMAX HEALTH PATIENT ACCESS CENTER

USPTO serial 86425868

EMAX HEALTH PATIENT ACCESS CENTER

Reviewed by CopyMark Law Group

Reg. 4780701Status 710
Filing date
Status date
Registration date
Jul 28, 2015
Examiner
REINHART, MEGHAN M
Law office
TMEG LAW OFFICE 108

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with EMAX HEALTH PATIENT ACCESS CENTER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Zaccaria

John Zaccaria Notaro, Michalos & Zaccaria P.C.100 Dutch Hill Road, Suite 240Orangeburg, NY 10962UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Pharmaceutical cost management services and drug utilization review services; health care utilization and review services; specialized pharmacy services for patients with particular medical conditions; health care cost review; health care cost containment; collection and compilation of information into computer databases in the fields of healthcare, pharmaceuticals, specialty pharmacy; market research; providing reimbursement information, drug pricing, payment tracking, co-payment data and other market intelligence to health care providers, insurers and consumers; managed care services, namely, utilization review and pre-certification services; electronic processing of health care information; business development services; promoting and marketing the brands of others; Business information services, namely, collection, reporting and analysis of healthcare data, namely, retail and specialty pharmacy data, clinical trials, medical data, insurance claims, hospital data, pharmaceuticals, namely, dosage, frequency, and clinical effectiveness and patient response to therapy, and scientific research in compiling data to determine the efficacy of biopharmaceutical products on a subset patient population for business purposes and for assisting decision making with respect to contracting with health insurance providers and pharmacy benefit managers to improve market access, formulary status, brand preferencing, and economic evaluation of rebate or discounting programsSECTION 8 - CANCELLEDJan 15, 2012
036Providing counseling and consulting in the field of healthcare benefits; providing information about healthcare insurance plans; providing a database featuring information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices; providing financial advice to patients; claims administration in the field of health insurance; insurance services, namely, benefits verification; debit card services; Healthcare research services, namely, providing information regarding health care insurance and payment options to health care providers, insurers, and consumers; Consulting services, namely, providing information about health care plans and medication options, products and programs, namely, benefit plansSECTION 8 - CANCELLEDJan 15, 2012
044Pharmaceutical advice; health care services, namely, providing a database of diseases and the collection of disease data and information all for treatment and diagnostic purposes; medical evaluation services, namely, functional assessment program for patients receiving medical rehabilitation services for purposes of guiding treatment and assessing program effectiveness; Healthcare research services, namely, providing information regarding health care treatment and specialty pharmaceuticals to health care providers, insurers, and consumersSECTION 8 - CANCELLEDJan 15, 2012

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 13, 2026CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Jan 22, 2025ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jul 28, 2024REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Dec 21, 2021NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Dec 21, 20218.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Dec 21, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 23, 2021ES8RTEAS SECTION 8 RECEIVED—
Jul 28, 2020REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jan 24, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 24, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 11, 2019CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 11, 2019COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 28, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 12, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 12, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 22, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 7, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 7, 2015ALIEASSIGNED TO LIE—
Mar 18, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 18, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Mar 18, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 18, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 18, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 11, 2015GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Feb 11, 2015GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Feb 11, 2015EPENCOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY—
Feb 11, 2015CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Feb 4, 2015DOCKASSIGNED TO EXAMINER—
Oct 24, 2014MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Oct 23, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 20, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance